{
  "kind": "treatment",
  "slug": "nicotine-patch-nicoderm",
  "type": "smoking-cessation",
  "name": "Nicotine Patch (Nicoderm)",
  "summary": "A transdermal nicotine replacement therapy (NRT) used to help people quit smoking by delivering a steady dose of nicotine through the skin.",
  "description": "The nicotine patch is a smoking cessation aid that provides continuous delivery of nicotine through the skin over 16 or 24 hours. It helps reduce cravings and withdrawal symptoms associated with quitting smoking. Patches come in various strengths to allow gradual tapering of nicotine dosage.",
  "category": "medications/smoking-cessation",
  "tags": [
    "smoking cessation",
    "nicotine replacement therapy",
    "NRT",
    "transdermal"
  ],
  "metadata": {
    "drug_classes": [
      "Nicotine Replacement Therapy"
    ],
    "therapeutic_categories": [
      "Addiction",
      "Smoking Cessation"
    ],
    "mechanism_categories": [
      "Other"
    ],
    "administration_routes": [
      "Patch"
    ],
    "prescription_status": "Over-the-Counter",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Nicoderm CQ",
      "Habitrol",
      "Nicotrol Patch"
    ],
    "dea_schedule": null,
    "fda_pregnancy_category": "D (risk if continued smoking outweighs NRT use; should be supervised)",
    "age_groups": [
      "Adult"
    ],
    "treatment_duration": [
      "Short-term",
      "Tapered use"
    ],
    "specialty_areas": [
      "Addiction Medicine",
      "Primary Care"
    ],
    "fda_approval_year": 1991
  },
  "clinical_metadata": {
    "primary_indications": [
      "Other"
    ],
    "off_label_uses": [
      "Smokeless tobacco cessation"
    ],
    "contraindications": [
      "Recent myocardial infarction",
      "Severe arrhythmia",
      "Uncontrolled hypertension",
      "Hypersensitivity to nicotine or patch adhesives"
    ],
    "monitoring_required": [
      "Signs of nicotine overdose",
      "Skin reactions at application site"
    ],
    "efficacy_rating": {
      "smoking_cessation": 3
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "nicotine patch",
      "Nicoderm",
      "smoking cessation",
      "nicotine replacement therapy",
      "NRT"
    ],
    "synonyms": [
      "nicotine transdermal patch"
    ],
    "common_misspellings": [
      "nicodermm",
      "nicotene patch"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Smoking cessation",
        "Smokeless tobacco cessation (off-label)"
      ]
    },
    {
      "type": "mechanism",
      "text": "Delivers nicotine through the skin into the bloodstream, stimulating nicotinic acetylcholine receptors to reduce cravings and withdrawal symptoms."
    },
    {
      "type": "dosing",
      "adult": {
        "typical": "21 mg/day for 6 weeks, then 14 mg/day for 2 weeks, then 7 mg/day for 2 weeks (for >10 cigarettes/day smokers)",
        "lower_use": "14 mg/day for 6 weeks, then 7 mg/day for 2 weeks (for ≤10 cigarettes/day smokers)"
      },
      "tapering": "Step-down approach using progressively lower dose patches"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Transdermal patches: 7 mg/24 hr, 14 mg/24 hr, 21 mg/24 hr"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Nicotine absorption begins within 30 minutes; provides steady levels over the patch's wear time (16 or 24 hours)."
    },
    {
      "type": "adverse_effects",
      "common": [
        "skin irritation",
        "vivid dreams",
        "insomnia",
        "headache",
        "nausea"
      ],
      "less_common": [
        "dizziness",
        "palpitations"
      ],
      "serious": [
        "allergic reactions to adhesives",
        "nicotine overdose"
      ]
    },
    {
      "type": "warnings",
      "other": [
        "Remove patch before MRI to avoid burns from metallic components",
        "Rotate application sites daily to minimize skin irritation"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "Other nicotine-containing products",
          "risk": "Nicotine toxicity",
          "action": "Avoid combination"
        },
        {
          "with": "CYP1A2 substrates",
          "risk": "Smoking cessation may alter drug metabolism",
          "action": "Monitor drug levels"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Skin reactions at application site",
        "Signs of nicotine overdose",
        "Blood pressure in hypertensive patients"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if benefits outweigh risks and under medical supervision",
      "lactation": "Nicotine passes into breast milk; avoid or use immediately after breastfeeding",
      "pediatrics": "Not recommended under age 18 without supervision"
    },
    {
      "type": "tapering",
      "text": "Reduce nicotine dose gradually over 8–10 weeks."
    },
    {
      "type": "clinical_notes",
      "items": [
        "May cause vivid dreams or insomnia—consider removing patch at night",
        "Useful for patients who prefer consistent nicotine delivery over the day"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Nicoderm CQ Product Information",
          "url": "https://www.nicodermcq.com/"
        },
        {
          "label": "US Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence",
          "url": "https://www.ahrq.gov/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Nicotine Patch (Nicoderm): Smoking Cessation Aid",
    "description": "Nicotine patches provide continuous nicotine delivery through the skin to reduce cravings and withdrawal symptoms during smoking cessation."
  }
}
